128 results
Page 2 of 7
8-K
EX-10.1
71ejqkhb
23 Nov 22
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-10.1
y1nlh7fqaqo
18 Oct 22
Entry into a Material Definitive Agreement
5:44pm
8-K
EX-10.2
z30osb
18 Oct 22
Entry into a Material Definitive Agreement
5:44pm
8-K
EX-10.1
yctdpba
20 Jul 22
Entry into a Material Definitive Agreement
7:01pm
8-K
EX-10.1
bq4trao8hqfw ts
17 Jun 22
Entry into a Material Definitive Agreement
5:22pm
8-K
EX-10.2
wx60xb38
23 May 22
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
cinlpf87pngsz ikqwj
23 May 22
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
hblbeqrjh2totp
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
EX-10.2
imokdpfmshuyyfe8iiyu
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
EX-10.1
e9en3l 8lvegdc
15 Oct 21
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
p30dry4sb tsqc5x
6 Oct 21
Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer
12:00am
8-K
EX-10.1
4h9 ukzjr9cfsee2
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am